TY - JOUR
T1 - Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device
AU - Travis, Adam R.
AU - Giridharan, Guruprasad A.
AU - Pantalos, George M.
AU - Dowling, Robert D.
AU - Prabhu, Sumanth D.
AU - Slaughter, Mark S.
AU - Sobieski, Mike
AU - Undar, Akif
AU - Farrar, David J.
AU - Koenig, Steven C.
N1 - Funding Information:
Funding for this project was provided by the Jewish Hospital Heart and Lung Research Foundation (Louisville, Ky) and an equipment grant from Thoratec Corporation (Pleasanton, Calif).
Funding Information:
Robert Dowling reports consulting fees from Abiomed and Circulite. Guruprasad Giridharan reports consulting fees from Abiomed. Steven Koenig reports consulting fees from Abiomed and grant support from Thoratec. George Pantalos reports consulting fees from Abiomed and equity ownership in Transonic Systems. Mark Slaughter reports speaker fees from Thoratec. This study was reported in part by a grant from Thoratec.
PY - 2007/2
Y1 - 2007/2
N2 - Objective: We sought to investigate differences in indices of pulsatility between patients with normal ventricular function and patients with heart failure studied at the time of implantation with continuous-flow or pulsatile-flow left ventricular assist devices. Methods: Eight patients with normal ventricular function and 22 patients with heart failure were studied. A high-fidelity aortic and left ventricular pressure catheter was inserted retrograde through the aortic valve into the left ventricle, and transit-time flow probes were placed on the aorta and device outflow graft. Hemodynamic waveforms were recorded at native heart rate before cardiopulmonary bypass and over a range of device flow rates controlled by adjusting beat rate or rpm. These data were used to calculate vascular input impedance and 2 indices of vascular pulsatility: energy-equivalent pressure and surplus hemodynamic energy. Results: At low support levels, pulsatile support restored surplus hemodynamic energy to within 2.5% of normal values, whereas continuous support diminished surplus energy by more than 93%. At high support levels, pulsatile support augmented surplus energy by 49% over normal values, whereas continuous support further diminished surplus energy by 97%. Pulsatile support diminished vascular impedance from baseline failure values, whereas continuous support increased impedance. Vascular impedances at baseline for patients undergoing pulsatile and continuous support and during pulsatile support revealed normal vascular compliance, whereas impedance during continuous support indicated a loss of compliance (or "stiffening") of the vasculature. Conclusion: These results suggest that selection of device type and flow rate can influence vascular pulsatility and input impedance, which might affect clinical outcomes.
AB - Objective: We sought to investigate differences in indices of pulsatility between patients with normal ventricular function and patients with heart failure studied at the time of implantation with continuous-flow or pulsatile-flow left ventricular assist devices. Methods: Eight patients with normal ventricular function and 22 patients with heart failure were studied. A high-fidelity aortic and left ventricular pressure catheter was inserted retrograde through the aortic valve into the left ventricle, and transit-time flow probes were placed on the aorta and device outflow graft. Hemodynamic waveforms were recorded at native heart rate before cardiopulmonary bypass and over a range of device flow rates controlled by adjusting beat rate or rpm. These data were used to calculate vascular input impedance and 2 indices of vascular pulsatility: energy-equivalent pressure and surplus hemodynamic energy. Results: At low support levels, pulsatile support restored surplus hemodynamic energy to within 2.5% of normal values, whereas continuous support diminished surplus energy by more than 93%. At high support levels, pulsatile support augmented surplus energy by 49% over normal values, whereas continuous support further diminished surplus energy by 97%. Pulsatile support diminished vascular impedance from baseline failure values, whereas continuous support increased impedance. Vascular impedances at baseline for patients undergoing pulsatile and continuous support and during pulsatile support revealed normal vascular compliance, whereas impedance during continuous support indicated a loss of compliance (or "stiffening") of the vasculature. Conclusion: These results suggest that selection of device type and flow rate can influence vascular pulsatility and input impedance, which might affect clinical outcomes.
UR - http://www.scopus.com/inward/record.url?scp=33846390671&partnerID=8YFLogxK
U2 - 10.1016/j.jtcvs.2006.09.057
DO - 10.1016/j.jtcvs.2006.09.057
M3 - Article
C2 - 17258591
AN - SCOPUS:33846390671
SN - 0022-5223
VL - 133
SP - 517
EP - 524
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 2
ER -